These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 929193)

  • 1. Polymorphonuclear leukocytes: possible mechanism of accumulation in psoriasis.
    Lazarus GS; Yost FJ; Thomas CA
    Science; 1977 Dec; 198(4322):1162-3. PubMed ID: 929193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemokinetic and chemotactic factors in psoriasis scale extracts.
    Dahl MV; Lindroos WE; Nelson RD
    J Invest Dermatol; 1978 Dec; 71(6):402-6. PubMed ID: 722120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monocyte and neutrophil chemotaxis in psoriasis. Relation to the clinical status and the type of psoriasis.
    Ternowitz T
    J Am Acad Dermatol; 1986 Dec; 15(6):1191-9. PubMed ID: 3027138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteinases of human epidermis; a possible mechanism for polymorphonuclear leukocyte chemotaxis.
    Levine N; Hatcher VB; Lazarus GS
    Biochim Biophys Acta; 1976 Dec; 452(2):458-67. PubMed ID: 1009122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a chemotactic and cytotoxic proteinase from human skin.
    Hatcher VB; Lazarus GS; Levine N; Burk PG; Yost FJ
    Biochim Biophys Acta; 1977 Jul; 483(1):160-71. PubMed ID: 69444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of some protease substrates and inhibitors on chemotaxis and protease activity of human polymorphonuclear leukocytes.
    Grady PG; Davis AT; Shapira E
    J Infect Dis; 1979 Dec; 140(6):999-1003. PubMed ID: 396341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Etretinate therapy reduces polymorphonuclear leukocyte chemotaxis--enhancing properties of psoriatic serum.
    Ellis CN; Kang S; Grekin RC; Voorhees JJ; Silva J
    J Am Acad Dermatol; 1985 Sep; 13(3):437-43. PubMed ID: 4056118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Migration-stimulating effect of psoriatic scales on polymorphonuclear leukocytes.
    Lidén S; Bäck O; Pettersson A
    Arch Dermatol Res; 1980; 269(1):93-8. PubMed ID: 7447494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neutrophil granulocyte chemotaxis and psoriasis].
    Christophers E; Schröder JM
    Hautarzt; 1981 Nov; 32(11):558-63. PubMed ID: 6458581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The activity of polymorphonuclear leukocyte neutral proteinases and their inhibitors in patients with psoriasis treated with a continuous peritoneal dialysis.
    Glinski W; Zarebska Z; Jabłonska S; Imiela J; Nosarzewski J
    J Invest Dermatol; 1980 Dec; 75(6):481-7. PubMed ID: 6777433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular serine proteinase induces chemotaxis by complement activation.
    Thomas CA; Yost FJ; Snyderman R; Hatcher VB; Lazarus GS
    Nature; 1977 Oct; 269(5628):521-2. PubMed ID: 909603
    [No Abstract]   [Full Text] [Related]  

  • 12. Neutrophil leukocyte migration in psoriasis vulgaris.
    Breathnach SM; Carrington P; Black MM
    J Invest Dermatol; 1981 Apr; 76(4):271-4. PubMed ID: 7205028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies of polymorphonuclear migration into psoriatic skin using a new in vivo method.
    Guillot B; Coupe M; Alirezai M; Bureau JP; Guilhou JJ
    Arch Dermatol Res; 1989; 280(8):477-80. PubMed ID: 2645836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotaxis inhibition induced in polymorphonuclear neutrophils by soluble immune complexes.
    Leung-Tack J; Maillard J; Voisin GA
    Int Arch Allergy Appl Immunol; 1979; 58(4):365-74. PubMed ID: 437907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of human neutrophil and eosinophil polymorphonuclear leukocyte chemotaxis: an analytical review.
    Valone FH
    Clin Immunol Immunopathol; 1980 Jan; 15(1):52-65. PubMed ID: 6987018
    [No Abstract]   [Full Text] [Related]  

  • 16. Neutrophil chemotaxis in psoriasis.
    Wahba A; Cohen H; Bar-Eli M; Callily R
    Acta Derm Venereol; 1979; 59(5):441-5. PubMed ID: 93368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of polymorphonuclear leukocyte capping by a chemotactic factor.
    Mandell BF; Spilberg I; Lichtman J
    J Immunol; 1977 Apr; 118(4):1375-8. PubMed ID: 321690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphonuclear leukocyte chemotaxis in psoriasis: enhancement by self-activated serum.
    Kawohl G; Szperalski B; Schröder JM; Christophers E
    Br J Dermatol; 1980 Nov; 103(5):527-33. PubMed ID: 7437318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a leukotactic factor derived from psoriatic scale.
    Tagami H; Ofuji S
    Br J Dermatol; 1977 Nov; 97(5):509-18. PubMed ID: 588464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphonuclear leukocyte chemotaxis in generalized pustular psoriasis.
    Zelickson BD; Pittelkow MR; Muller SA; Johnson CM
    Acta Derm Venereol; 1987; 67(4):326-30. PubMed ID: 2445152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.